The generic name of Gansulin is 30/70 Mixed Recombinant Human Insulin Injection, and the generic name of Novalin is Arginine Biosynthetic Human Insulin Injection, both of them can lower blood glucose and are used for the treatment of type 1 or type 2 diabetes mellitus, and it is difficult to conclude which one is more effective in lowering blood glucose. Adverse reactions to 30/70 Mixed Recombinant Human Insulin Injection include localized redness, swelling and itching at the injection site. It is prohibited for patients with insulin allergy. Use is contraindicated in hypoglycemia. Adverse reactions to Arginine Biosynthetic Human Insulin Injection include rubella, eczema, and allergic reactions. It is contraindicated for those who are allergic to the active ingredient or other ingredients in this product. It is contraindicated in hypoglycemic episodes. The indications of the two are the same, there is no which one is better, if you have the need for medication, you need to use it under the guidance of a doctor in conjunction with your own condition, do not blindly use the medication on your own, so as not to cause adverse consequences.